Context Therapeutics Inc (CNTX)
2.005
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.1021M |
| Date | Value |
|---|---|
| December 31, 2021 | 54.23M |
| September 30, 2021 | -0.8169M |
| June 30, 2021 | 1.948M |
| March 31, 2021 | 3.034M |
| December 31, 2020 | 0.35M |
| September 30, 2020 | 0.45M |
| June 30, 2020 | 0.3241M |
| March 31, 2020 | 0.025M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.8169M
Minimum
Sep 2021
54.23M
Maximum
Dec 2021
3.963M
Average
--
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 40.70M |
| AbbVie Inc | 10.82B |
| Revance Therapeutics Inc | 92.83M |
| Design Therapeutics Inc | 0.02M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.361M |
| Free Cash Flow | -19.68M |
| Free Cash Flow Per Share (Quarterly) | -0.2731 |
| Free Cash Flow Yield | -61.48% |